zileuton has been researched along with Sjogren-Larsson Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afenjar, A; Boespflug-Tanguy, O; Pichard, S; Sarret, C | 1 |
| Heerschap, A; Mayatepek, E; Rotteveel, JJ; Steijlen, PM; Willemsen, MA | 1 |
| Cruysberg, JR; Lutt, MA; Mayatepek, E; Nijhuis-van der Sanden, MW; Pasman, JW; Rotteveel, JJ; Steijlen, PM; van der Graaf, M; Willemsen, MA | 1 |
3 other study(ies) available for zileuton and Sjogren-Larsson Syndrome
| Article | Year |
|---|---|
Lack of Long-Term Neurologic Efficacy of Zileuton in Sjögren-Larsson's Syndrome.
Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Hydroxyurea; Infant; Lipoxygenase Inhibitors; Male; Outcome Assessment, Health Care; Sjogren-Larsson Syndrome | 2017 |
5-Lipoxygenase inhibition: a new treatment strategy for Sjögren-Larsson syndrome.
Topics: Aldehyde Oxidoreductases; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydroxyurea; Leukotriene B4; Lipoxygenase Inhibitors; Sjogren-Larsson Syndrome | 2000 |
Clinical and biochemical effects of zileuton in patients with the Sjögren-Larsson syndrome.
Topics: Adolescent; Adult; Brain; Electroencephalography; Female; Humans; Hydroxyurea; Lipoxygenase Inhibitors; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neuropsychological Tests; Sjogren-Larsson Syndrome | 2001 |